Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can an app ease PTSD? new trial seeks answers

NCT ID NCT06589505

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a software program designed to reduce symptoms of post-traumatic stress disorder (PTSD). About 52 adults with PTSD will use the software or a placebo version. Researchers will measure changes in PTSD severity using a standard scale over the study period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

About 52 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of PTSD according to the DSM-5 * Subjects who are within 1 to 20 years since index trauma Exclusion Criteria: * Subjects diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, bipolar I disorder, autism spectrum disorder, or intellectual disability based on DSM-5. * Subjects diagnosed with any mood disorder and anxiety disorder according to DSM-5 that is the primary focus of treatment in the last 6 months prior to screening, as per the clinical judgement of the investigator * Subjects who have completed two or more full courses of trauma-focused therapy in the past

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post traumatic stress disorder PTSD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    35 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aburayama Hospital

    RECRUITING

    Fukuoka, Japan

  • Ai Mental Clinic

    RECRUITING

    Tochigi, Japan

  • Ai Sakura Clinic

    RECRUITING

    Fukuoka, Japan

  • Arata Clinic

    RECRUITING

    Nagasaki, Japan

  • Barclay Imuro Mental Clinic

    RECRUITING

    Okinawa, Japan

  • Goryokai Hospital

    RECRUITING

    Hokkaido, Japan

  • Hatakeyama Clinic

    RECRUITING

    Fukuoka, Japan

  • Heart Care Clinic Omachi

    RECRUITING

    Akita, Japan

  • Hiro Mental Clinic

    RECRUITING

    Fukuoka, Japan

  • Hirota Clinic

    RECRUITING

    Fukuoka, Japan

  • Iidabashi Mental Clinic

    RECRUITING

    Tokyo, Japan

  • Ikebukuro Olive Mental Clinic

    RECRUITING

    Tokyo, Japan

  • Kitaikebukuro Kokoro No Clinic

    RECRUITING

    Tokyo, Japan

  • Kurume University Hospital

    RECRUITING

    Fukuoka, Japan

  • Maynds Tower Mental Clinic

    RECRUITING

    Tokyo, Japan

  • Medical Corporation Mikokorokai Shimizu Clinic

    RECRUITING

    Osaka, Japan

  • Medical corporation Shinseikai Kaku Mental Clinic

    RECRUITING

    Fukuoka, Japan

  • Mental Clinic Sakurazaka

    RECRUITING

    Fukuoka, Japan

  • Monzennakacho Mental Clinic

    RECRUITING

    Tokyo, Japan

  • Musashikosugi J Kokorono Clinic

    RECRUITING

    Kanagawa, Japan

  • Niki Hearty Hospital

    RECRUITING

    Kumamoto, Japan

  • Nippon Medical School Hospital

    RECRUITING

    Tokyo, Japan

  • Nishie Kokorono Clinic

    RECRUITING

    Fukuoka, Japan

  • Okayama Psychiatric Medical Center

    RECRUITING

    Okayama, Japan

  • PTSD Care Matsumoto Mental Clinic

    RECRUITING

    Gunma, Japan

  • Sakamoto Misako Mental Clinic

    RECRUITING

    Hyōgo, Japan

  • Sakurazaka Clinic SophyAnce

    RECRUITING

    Tokyo, Japan

  • Sangenjaya Nakamura Mental Clinic

    RECRUITING

    Tokyo, Japan

  • Sho Midori Hospital

    RECRUITING

    Saitama, Japan

  • Takahashi Psychiatric Clinic

    RECRUITING

    Hyōgo, Japan

  • Tsukuba Psychosomatics Clinic

    RECRUITING

    Ibaraki, Japan

  • Uematsu Mental Clinic

    RECRUITING

    Fukuoka, Japan

  • Wakamatsucho Kokoro to Hifu Clinic

    RECRUITING

    Tokyo, Japan

  • Yamanashi Prefectural Kita Hospital

    RECRUITING

    Yamanashi, Hokkaido, Japan

  • i Kokoro Clinic Nihonbashi

    RECRUITING

    Tokyo, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.